These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 34323939)

  • 1. Prothrombotic immune thrombocytopenia after COVID-19 vaccination.
    Tiede A; Sachs UJ; Czwalinna A; Werwitzke S; Bikker R; Krauss JK; Donnerstag F; Weißenborn K; Höglinger G; Maasoumy B; Wedemeyer H; Ganser A
    Blood; 2021 Jul; 138(4):350-353. PubMed ID: 34323939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on vaccine induced thrombotic thrombocytopenia.
    Dotan A; Shoenfeld Y
    J Autoimmun; 2021 Jul; 121():102663. PubMed ID: 34020254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
    N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
    Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
    Scully M; Singh D; Lown R; Poles A; Solomon T; Levi M; Goldblatt D; Kotoucek P; Thomas W; Lester W
    N Engl J Med; 2021 Jun; 384(23):2202-2211. PubMed ID: 33861525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uncommon thrombotic complications after SARS-CoV-2 vaccination].
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
    Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
    Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia.
    Panagiota V; Dobbelstein C; Werwitzke S; Ganser A; Cooper N; Sachs UJ; Tiede A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.
    Handtke S; Wolff M; Zaninetti C; Wesche J; Schönborn L; Aurich K; Ulm L; Hübner NO; Becker K; Thiele T; Greinacher A
    Blood; 2021 Jul; 137(26):3656-3659. PubMed ID: 33945605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
    Kenda J; Lovrič D; Škerget M; Milivojević N
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.
    von Hundelshausen P; Lorenz R; Siess W; Weber C
    Thromb Haemost; 2021 Nov; 121(11):1395-1399. PubMed ID: 33851389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea.
    Choi JK; Kim S; Kim SR; Jin JY; Choi SW; Kim H; Yoo JH; Park IS; Kim SR
    J Korean Med Sci; 2021 Aug; 36(31):e223. PubMed ID: 34402235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
    De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
    Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
    Kircheis R
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
    Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.